Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52 Week Results from a Phase 3 Study

被引：0

作者：

Mease, Philip J. ^{[1
,2
]}

Okada, Masato ^{[3
]}

Kishimoto, Mitsumasa ^{[3
]}

Shuler, Catherine L. ^{[4
]}

Carlier, Hilde ^{[4
]}

Lin, Chen-Yen ^{[4
]}

Mou, Jiani ^{[4
]}

Moriarty, Susan R. ^{[4
]}

Lee, Chin H. ^{[4
]}

Gladman, Dafna D. ^{[5
]}

机构：

[1] Swedish Med Ctr, Rheumatol & Internal Med, Seattle, WA USA

[2] Univ Washington, Seattle, WA 98195 USA

[3] St Lukes Int Hosp, Immunorheumatol Ctr, Tokyo, Japan

[4] Eli Lilly & Co, Indianapolis, IN 46285 USA

[5] Univ Toronto, Toronto, ON, Canada

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

959

引用

页数：2